Prior Biologic Use Tied to JAK Inhibitor Benefit in Ulcerative Colitis

(MedPage Today) — LAS VEGAS — Prior exposure to anti-tumor necrosis factor (TNF) therapy was associated with a lower risk of colectomy among patients receiving Janus kinase (JAK) inhibitor rescue therapy for acute severe ulcerative colitis…

Source link : https://www.medpagetoday.com/meetingcoverage/ccc/119560

Author :

Publish date : 2026-01-23 20:10:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Prior Biologic Use Tied to JAK Inhibitor Benefit in Ulcerative Colitis

Aortic Emergencies More Likely After Cold Temps

Congress Pressed on NIH Neurology Leadership Change

Related Posts

‘Two weeks will make such a difference’: UK first as NI brings in miscarriage leave

‘Not a Little Higher. It’s Much Higher. It’s Incredible’: What We Heard This Week

The Most Honest Health Conversations May Be Those the Law Doesn’t Protect

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Quiz Time: What Drug Was Tied to 8 Deaths?

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

‘Two weeks will make such a difference’: UK first as NI brings in miscarriage leave

‘Not a Little Higher. It’s Much Higher. It’s Incredible’: What We Heard This Week

The Most Honest Health Conversations May Be Those the Law Doesn’t Protect

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

Quiz Time: What Drug Was Tied to 8 Deaths?

Dulaglutide or Tirzepatide? Worldwide Biopharma Changes

Beyond the Paywall: The Cost of Lack of Research Access

To Fix a Patient’s Irregular Heartbeat, Doctors First Tested Its Digital ‘Twin’

Categories

Archives